Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

T Wästerlid; J L Biccler; P N Brown; M Bøgsted; G Enblad; J Mészáros Jørgensen; J H Christensen; B E Wahlin; K E Smedby; T C El-Galaly; M Jerkeman

doi:10.1093/annonc/mdy184

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

T Wästerlid, J L Biccler, P N Brown, M Bøgsted, G Enblad, J Mészáros Jørgensen, J H Christensen, B E Wahlin, K E Smedby, T C El-Galaly, M Jerkeman

Institut for Klinisk Medicin

5 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Annals of oncology : official journal of the European Society for Medical Oncology
Vol/bind	29
Udgave nummer	8
Sider (fra-til)	1882-1883
Antal sider	2
ISSN	0923-7534
DOI	https://doi.org/10.1093/annonc/mdy184
Status	Udgivet - aug. 2018

Adgang til dokumentet

10.1093/annonc/mdy184

Six_cycles_of_R_CHOP_21_are_not_inferior_to_eight_cycles_for_treatment_of_diffuse_large_B_cell_lymphoma_A_Nordic_Lymphoma_Group_population_based_study.pdfForlagets udgivne version, 441 KB

Citationsformater

Wästerlid, T., Biccler, J. L., Brown, P. N., Bøgsted, M., Enblad, G., Mészáros Jørgensen, J., Christensen, J. H., Wahlin, B. E., Smedby, K. E., El-Galaly, T. C., & Jerkeman, M. (2018). Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study. Annals of oncology : official journal of the European Society for Medical Oncology, 29(8), 1882-1883. https://doi.org/10.1093/annonc/mdy184

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma : a Nordic Lymphoma Group Population-based Study. / Wästerlid, T; Biccler, J L; Brown, P N et al.

I: Annals of oncology : official journal of the European Society for Medical Oncology, Bind 29, Nr. 8, 08.2018, s. 1882-1883.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Wästerlid, T, Biccler, JL, Brown, PN, Bøgsted, M, Enblad, G, Mészáros Jørgensen, J, Christensen, JH, Wahlin, BE, Smedby, KE, El-Galaly, TC & Jerkeman, M 2018, 'Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study', Annals of oncology : official journal of the European Society for Medical Oncology, bind 29, nr. 8, s. 1882-1883. https://doi.org/10.1093/annonc/mdy184

Wästerlid T, Biccler JL, Brown PN, Bøgsted M, Enblad G, Mészáros Jørgensen J et al. Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 aug.;29(8):1882-1883. doi: 10.1093/annonc/mdy184

@article{99e9fcb29b1442cbb1e16cc4c3ac93b4,

title = "Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study",

author = "T W{\"a}sterlid and Biccler, {J L} and Brown, {P N} and M B{\o}gsted and G Enblad and {M{\'e}sz{\'a}ros J{\o}rgensen}, J and Christensen, {J H} and Wahlin, {B E} and Smedby, {K E} and El-Galaly, {T C} and M Jerkeman",

year = "2018",

month = aug,

doi = "10.1093/annonc/mdy184",

language = "English",

volume = "29",

pages = "1882--1883",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma

T2 - a Nordic Lymphoma Group Population-based Study

AU - Wästerlid, T

AU - Biccler, J L

AU - Brown, P N

AU - Bøgsted, M

AU - Enblad, G

AU - Mészáros Jørgensen, J

AU - Christensen, J H

AU - Wahlin, B E

AU - Smedby, K E

AU - El-Galaly, T C

AU - Jerkeman, M

PY - 2018/8

Y1 - 2018/8

U2 - 10.1093/annonc/mdy184

DO - 10.1093/annonc/mdy184

M3 - Journal article

C2 - 29790897

SN - 0923-7534

VL - 29

SP - 1882

EP - 1883

JO - Annals of Oncology

JF - Annals of Oncology

IS - 8

ER -